SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQs sharp after-hours drop drew attention as traders linked the move to the FAAs nationwide ground stop after communications problems, while speculation about a cyberattack or AI involvement remained unverified. The discussion also reflected wider pressure on tech and AI stocks tied to uncertainty around Nvidia, with traders divided between seeing the selloff as an overreaction and expecting further weakness.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summits FDA review of ivonescimab for EGFR-mutated lung cancer is driving a binary-outcome debate over approval versus a possible rejection or request for more evidence. Bulls point to strong progression-free-survival results and encouraging survival trends, while bears focus on the FDAs stated need for statistically significant overall-survival evidence; recent weakness has also prompted speculation about a negative outcome, though traders say price action alone is not proof.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The upcoming Phase 3 REGAL trial readout for SELLASs AML treatment GPS dominates discussion, with traders focused on the binary clinical catalyst. Bulls anticipate strong results, while skeptics cite the stocks sharp volatility and warn of failure risk or a sell-the-news reaction; claims of short-term manipulation remain speculation.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians volatile, weak share performance is driving debate, with traders blaming heavy short-selling and persistent selling pressure while bulls point to improving deliveries, the R2 ramp, and upcoming autonomy developments. Sentiment remains split between concern over cash burn and execution and hopes that the companys growth initiatives can improve its outlook.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

Reports of an FAA nationwide ground stop tied to air-traffic-control communications problems are drawing attention to AAL, with traders discussing possible departure delays and rerouting. Some characterize the disruption as brief, while speculation about its cause remains unverified.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Reported takeover discussions involving Silver Lake and Saudi Arabias PIF are driving speculation, though no deal is confirmed; traders disagree over whether a potential offer would undervalue Unity. The interest is reinforced by strong quarterly results and the companys first GAAP-profitable quarter, with bullish call activity and breakout chatter alongside skepticism about the rally.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius selloff is being tied to its earnings outlook and delays in activating third-party data-center capacity, which push expected revenue into a later period and have prompted analyst price-target cuts. Traders are divided between viewing the execution and heavy-capex concerns as a reason for further downside and treating the drop as an overreaction, with broader weakness in AI and neocloud stocks adding pressure.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novos stronger-than-expected quarterly results and raised full-year outlook, driven largely by demand for its Wegovy pill, have fueled renewed buying interest. Traders are debating whether the oral drugs momentum can support a sustained recovery amid Lilly competition and concerns about Novos execution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs abrupt departure is driving debate over Nvidias leadership transition, with traders speculating about his return and possible successors while others worry about leadership uncertainty and scrutiny of chip exports to China. Bulls argue Nvidias business remains strong and point to earnings, while bears see unresolved risks weighing on confidence.

HawKeye 360, Inc. engages in the provision of defense technology. It offers spectrum monitoring, maritime intelligence, air defence radar monitoring, GNSS interference detection, and communications mapping. Its costumers include a wide range of commercial, government and international entities. The company was founded by Charles T. Clancy, Robert G. McGwier, Chris DeMay and John Serafini in 2015 and is headquartered in Herndon, VA.

HawkEye 360 Inc.

HAWK is drawing attention after reporting record third-quarter revenue and raising its full-year outlook, with traders also highlighting international growth, contract demand, and plans for lower-cost satellites. The community reaction is broadly bullish on the results and rally, though claims of institutional accumulation and further upside remain speculative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Upgrades Dynavax Technologies (NASDAQ:DVAX) to "Strong-Buy"

Wall Street Zen raised Dynavax Technologies to a "strong-buy" rating in a research note on Saturday...

Dynavax Technologies (DVAX) Projected to Post Quarterly Earnings on Thursday

Dynavax Technologies (NASDAQ:DVAX) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 19. (View Earnings Report at...

Dynavax Technologies Corporation (NASDAQ:DVAX) Given Consensus Rating of "Hold" by Brokerages

Dynavax Technologies Corporation (NASDAQ:DVAX - Get Free Report) has been assigned an average recommendation of "Hold" from the five brokerages that are presently covering the company, Marketbeat.com...

Short Interest in Dynavax Technologies Corporation (NASDAQ:DVAX) Declines By 14.0%

Dynavax Technologies Corporation (NASDAQ:DVAX - Get Free Report) was the recipient of a significant drop in short interest during the month of January. As of January 15th, there was short interest...

AlphaQuest LLC Boosts Stock Position in Dynavax Technologies Corporation $DVAX

AlphaQuest LLC grew its holdings in Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) by 109.9% during the third quarter, according to the company in its most recent disclosure with the...

Great Lakes Advisors LLC Has $3.36 Million Position in Dynavax Technologies Corporation $DVAX

Great Lakes Advisors LLC lessened its stake in Dynavax Technologies Corporation (NASDAQ:DVAX - Free Report) by 47.9% in the 3rd quarter, according to its most recent 13F filing with the Securities...

Sanofi Beats on Q4 Earnings, Expects Profitable Growth in 2026

SNY tops Q4 earnings estimates, as Dupixent surges. It guides faster profit growth than sales in 2026, even as revenues narrowly miss

Dynavax Technologies (NASDAQ:DVAX) COO Sells $1,782,960.00 in Stock

Dynavax Technologies Corporation (NASDAQ:DVAX - Get Free Report) COO David Novack sold 114,000 shares of the firm's stock in a transaction on Thursday, January 15th. The stock was sold at an average...

Dynavax Technologies (NASDAQ:DVAX) Stock Passes Above 200 Day Moving Average - Time to Sell?

Dynavax Technologies (NASDAQ:DVAX) Shares Cross Above 200-Day Moving Average - Here's Why...

Dynavax Technologies (NASDAQ:DVAX) Sets New 12-Month High - Still a Buy?

Dynavax Technologies (NASDAQ:DVAX) Hits New 12-Month High - Here's What Happened...

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Retail’s Christmas Eve Watchlist: Omeros, Nike, Citi, Dynavax And Agios Spark Most Market Chatter

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>The list included companies from healthcare, consumer, and banking.</li><li>The stocks were among the most discussed names during the Christmas Eve session.</li><li>Trading took place during a shortened U.S. market session.</li></ul><p>U.S. stocks finished the shortened Christmas Eve session on a firm footing, with the S&amp;P 500 touching a fresh record as investors leaned into expectations for interest-rate cuts in the year ahead.&nbsp;</p><p>Optimism was supported by data showing the U.S. economy expanded at its fastest pace in two years during the third quarter, while a drop in new jobless claims on Wednesday pointed to continued resilience in the labor market.</p><p>The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was up 0.5% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq 100 index, gained 0.3%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which tracks the Dow Jones Industrial Average, rose 0.6%.</p><h3 class="st-heading-3"><strong>Here’s a look at the names that drew the most buzz:</strong></h3><h2 class="st-heading-2"><strong><u>Omeros Corporation (OMER)</u></strong></h2><p>Omeros surged 67% in Wednesday’s midday session following its long-awaited&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/omeros-stock-jumps-premarket-after-fda-approves-first-drug-for-rare-transplant-complication/cLesxhYREvL">FDA approval for Yartemlea</a>, the first and only treatment approved for the rare and often-fatal transplant complication TA-TMA. The green light paves the way for a U.S. launch in the first half of next year.</p><p><a href="https://stocktwits.com/symbol/OMER">OMER stock</a> is up 69% year-to-date.</p><h2 class="st-heading-2"><strong><u>Nike (NKE)</u></strong></h2><p>Nike climbed 5% in Wednesday’s midday session after a regulatory filing showed board member&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nike-stock-pops-after-hours-as-apple-s-tim-cook-buys-nearly-3-m-in-shares-amid-turnaround-effort/cLeqcjTREHl">Tim Cook made a nearly $3 million</a> open-market purchase of the stock. The buy stood out as a show of confidence as the company navigates a multi-year turnaround under returning CEO Elliott Hill, even as tariffs and a cautious holiday outlook continue to weigh on sentiment.</p><p><a href="https://stocktwits.com/symbol/NKE">NKE stock</a> is up 5% year-to-date.</p><h2 class="st-heading-2"><strong><u>Citigroup (C)</u></strong></h2><p>Citigroup rose 2% in Wednesday’s midday session and extended a powerful rally, pushing&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/citi-stock-hits-highest-levels-since-2008-factors-at-play/cLetR7ZREvo">shares to levels last seen since 2008</a>. The stock has logged gains in most recent sessions as investors responded to upbeat brokerage calls, easing regulatory pressure and a sweeping internal overhaul aimed at boosting returns and simplifying the business.</p><p>C<a href="https://stocktwits.com/symbol/NVO"> stock</a> is up 2% year-to-date.</p><h2 class="st-heading-2"><strong><u>Dynavax Technologies (DVAX)</u></strong></h2><p>Dynavax jumped 38% in Wednesday’s midday session after&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-dynavax-stock-surge-38-in-premarket-today/cLesA4mREHU">Sanofi agreed to buy the vaccine maker</a> for $2.2 billion in cash. The deal adds Dynavax’s hepatitis B vaccine and pipeline assets to Sanofi’s portfolio and marked one of the day’s clearest takeover-driven moves.</p><p><a href="https://stocktwits.com/symbol/DVAX">DVAX stock</a> is up 38% year-to-date.</p><h2 class="st-heading-2"><strong><u>Agios Pharmaceuticals (AGIO)</u></strong></h2><p>Agios rallied 18% in Wednesday’s midday session after the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-agio-stock-surge-14-today/cLesxI9REvh">FDA approved Aqvesme</a>, an oral therapy for anemia in adults with alpha- or beta-thalassemia. The approval, backed by late-stage trial data, positions Aqvesme as the only FDA-approved treatment across both transfusion-dependent and non-dependent forms of the disease, with a U.S. launch expected next month.</p><p><a href="https://stocktwits.com/symbol/AGIO">AGIO stock</a> is up 18% year-to-date.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

With holiday festivities officially beginning in New York with the Thanksgiving Day Parade on Thursday, Santa Claus and elves visited the New York Stock Exchange (NYSE) on November 26, 2025. (Photo by Spencer Platt/Getty Images)

The stocks were tracked during the shortened Christmas Eve session across healthcare, consumer, and banking.

Agios Pharmaceuticals Inc

Citigroup Inc

Nike Inc

Omeros Corp

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

DVAX News